This post has been archived and contains information that may be out of date.
In response to providers’ recent challenges implementing new requirements for opioid prescriptions, the governor has signed into law a bill that allows a transition period before the requirements become effective.
Under a 2018 bill — Assembly Bill (AB) 1753 — controlled substance security prescription forms must include a new, unique serial number in a format approved by the Department of Justice. However, because that legislation did not allow for a transition period, its requirements took effect Jan. 1 — before the new forms were widely available. Yesterday, the governor signed AB 149 (Chapter 4, Statutes of 2019), which allows for a transition period until Jan. 1, 2021. The bill also allows the Department of Justice to extend this period to ensure adequate supply.
